The hypothesis is that the "uro-selective" alpha blocker Silodosin improves bladder emptying in women with MS
ID
Bron
Verkorte titel
Aandoening
Multiple Sclerosis
MS
neurogene blaas
neurogenic bladder
residual urine
urine residu
bladder residual volume
blaasresidu
alpha blockers
alpha blokkers
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
- Residual urine
Achtergrond van het onderzoek
This study is a prospective, placebo-controlled, double-blind, randomized study.
The objective of the study is to investigate if the alpha blocker Silodosin improves the bladder emptying and the quality of life in patients with MS.
30 female patients (18 years or older) with relapsing-remitting MS and bladder emptying dysfunction will be recruited and divided into 2 groups of 15 patients. One group receives Silodosine for 6 weeks and one group receives placebo. Residual urine and quality of life and symptom score questionnaires will be measured at t = 0 en t = 6 weeks.
Doel van het onderzoek
The hypothesis is that the "uro-selective" alpha blocker Silodosin improves bladder emptying in women with MS
Onderzoeksopzet
At t=0 and t=6 weeks.
Onderzoeksproduct en/of interventie
The investigational product is Silodosin, a "uro-selective" alpha blockers. The dosage is 8 mg once daily per os. One group receives Silodosin for 6 weeks while the second group is treated with a placebo during the same period.
Publiek
Sarah H.M. Reuvers
Wytemaweg 80
Rotterdam 3015 CN
The Netherlands
Tel: +31 (0) 10 – 703 10 39
s.reuvers@erasmusmc.nl
Wetenschappelijk
Sarah H.M. Reuvers
Wytemaweg 80
Rotterdam 3015 CN
The Netherlands
Tel: +31 (0) 10 – 703 10 39
s.reuvers@erasmusmc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Female
- Age 18 years or older
- Relapsing-remitting MS
- Residual urine 80 ml ¡§C 250 ml
- Adequate understanding of the Dutch language
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Dependency of wheel chair
- Being bedridden
- Indwelling catheter
- Clean intermittent catheterization
- Acute attack of MS
- Current treatment with an alpha-blocker
- Pregnancy/breastfeeding
- Severe kidney dysfunction
- Orthostatic hypotension
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL5545 |
| NTR-old | NTR5666 |
| CCMO | NL54539.078.15 |
| OMON | NL-OMON47090 |